The Neonatal Detection of Cystic Fibrosis by Measurement of Immunoreactive Trypsin in Blood

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Annals of Clinical Biochemistry

• Publication date

  1992-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/000456329202900401PMID 1642442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009cited by this paper
• Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.

  1991cited by this paper
• Abnormal frequency of ΔF508 mutation in neonatal transitory hypertrypsinaemia

  1991cited by this paper
• The international quality assurance program (IRTIQAS) for the assay of immunoreactive trypsin in dried blood spots

  1991cited by this paper
• Pathogenesis and management of lung disease in cystic fibrosis.

  1991cited by this paper
• Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.

  1991cited by this paper
• Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.

  1991cited by this paper
• The cystic fibrosis gene: medical and social implications for heterozygote detection.

  1990cited by this paper
• An evaluation of an enzyme immunoassay method for immunoreactive trypsin in dried blood spots.

  1990cited by this paper
• [A new strategy of neonatal screening for cystic fibrosis. The association of immunoreactive trypsin and molecular biology in dried blood].

  1990cited by this paper
• Screening for cystic fibrosis: use of delta F508 mutation.

  1990cited by this paper
• Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.

  1990cited by this paper
• Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program

  1990cited by this paper
• Screening for cystic fibrosis: use of delta F508 mutation.

  1990cited by this paper
• Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.

  1990cited by this paper
• Cystic fibrosis. A transport problem?

  1990cited by this paper
• A transport problem?

  1990cited by this paper
• Purification and reconstitution of chloride channels from kidney and trachea

  1989cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis.

  1989cited by this paper
• The Metabolic basis of inherited disease

  1989cited by this paper
• Screening for cystic fibrosis

  1989cited by this paper
• Identification of the cystic fibrosis gene: Chromosome walking and jumping

  1989cited by this paper
• Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening.

  1989cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989cited by this paper
• Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase.

  1989cited by this paper
• Experience with neonatal screening for cystic fibrosis in New Zealand using measurement of immunoreactive trypsinogen

  1989cited by this paper
• Neonatal screening for cystic fibrosis.

  1988cited by this paper
• Plasma immunoreactive-trypsin(ogen) levels during development.

  1988cited by this paper
• Screening for cystic fibrosis: a four year regional experience.

  1988cited by this paper
• Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique.

  1988cited by this paper
• An evaluation of screening for cystic fibrosis.

  1987cited by this paper
• Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats.

  1987cited by this paper
• Phosphorylation fails to activate chloride channels from cystic fibrosis airway cells

  1987cited by this paper
• Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis.

  1987cited by this paper
• Screening for Cystic Fibrosis

  1987cited by this paper
• Neonatal screening for cystic fibrosis.

  1986cited by this paper
• Age-Related Alterations of Immunoreactive Pancreatic Cationic Trypsinogen in Sera from Cystic Fibrosis Patients with and without Pancreatic Insufficiency

  1986cited by this paper
• Trypsin‐Binding Immunoglobulin G in Cystic Fibrosis, Allergic, and Normal Children

  1986cited by this paper
• Neonatal screening for cystic fibrosis.

  1986cited by this paper
• Physiologically elevated concentration of serum trypsin-like immunoreactivity in newborns. Comparison with lipase.

  1986cited by this paper
• Reduced morbidity in patients with cystic fibrosis detected by neonatal screening.

  1985cited by this paper
• Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis.

  1985cited by this paper
• Radioimmunoassay of cationic trypsin-like immunoreactivity in man.

  1984cited by this paper
• Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin.

  1984cited by this paper
• Characterization and N-terminal sequence of a degradation product of 14,000 molecular weight isolated from human pancreatic juice.

  1984cited by this paper
• Neonatal Screening for Cystic Fibrosis: Position Paper

  1983cited by this paper
• Diagnostic delay in cystic fibrosis: lessons from newborn screening.

  1983cited by this paper
• Chloride impermeability in cystic fibrosis

  1983cited by this paper
• Cystic fibrosis--its biochemical detection.

  1983cited by this paper
• Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants.

  1983cited by this paper
• Conclusions from a pilot immunoreactive trypsin newborn screen for cystic fibrosis.

  1983cited by this paper
• Screening for cystic fibrosis by died blood spot trypsin assay.

  1982cited by this paper
• IMMUNOREACTIVE TRYPSIN SCREENING FOR CYSTIC FIBROSIS

  1982cited by this paper
• Cathodic trypsin-like immunoreactivity in serum: influence of sex, age, renal function, food and diurnal variation.

  1982cited by this paper
• Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.

  1981cited by this paper
• Radioimmunoassay determination of circulating pancreatic endopeptidases.

  1981cited by this paper
• Two tier screen for cystic fibrosis.

  1981cited by this paper
• Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.

  1981cited by this paper
• Use of a dried blood spot in immunoreactive-trypsin assay for detection of cystic fibrosis in infants.

  1981cited by this paper
• [Radioimmunoassay of trypsin in dried blood. Importance for the neonatal detection of cystic fibrosis (author's transl)].

  1981cited by this paper
• Plasma trypsin-like immunoreactivity in normal subjects and in patients with pancreatic diseases.

  1980cited by this paper
• Screening of newborns for cystic fibrosis.

  1980cited by this paper
• Radioimmunoassay of trypsin-like substance in human serum.

  1980cited by this paper
• Clearance of circulating anionic and cationic pancreatic trypsinogens in the rat.

  1980cited by this paper
• DRIED BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS

  1979cited by this paper
• Dried-blood spot screening for cystic fibrosis in the newborn.

  1979cited by this paper
• Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis.

  1979cited by this paper
• Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.

  1979cited by this paper
• Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma.

  1979cited by this paper
• Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants.

  1979cited by this paper
• Units for immunoreactive trypsin.

  1979cited by this paper
• Penicillinase—Producing Gonococci

  1978cited by this paper
• Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay.

  1978cited by this paper
• Studies on the turnover of endogenous cathodal trypsinogen in man

  1978cited by this paper
• Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin.

  1977cited by this paper
• The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs.

  1977cited by this paper
• Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma.

  1976cited by this paper
• Radioimmunoassay of human plasma trypsin.

  1976cited by this paper
• Selection of diseases and tests in pediatric screening.

  1974cited by this paper
• Cystic fibrosis of the pancreasの1例

  1974cited by this paper
• Human Pancreatic Proteolytic Enzymes and Protein Inhibitors

  1974cited by this paper
• Cystic fibrosis of the pancreas. Morphologic findings in infants with and without diagnostic pancreatic lesions.

  1973cited by this paper
• Human pancreatic enzymes. Characterization of anionic huyman trypsin.

  1973cited by this paper
• Life tables for cystic fibrosis.

  1971cited by this paper
• Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period.

  1970cited by this paper
• Human trypsin. Isolation and physical-chemical characterization.

  1969cited by this paper
• Cystic fibrosis of the pancreas.

  1958cited by this paper

• The effect of inadequate drying of blood spots on newborn screening analyte concentrations

  2025cites this paper
• Serum trypsin is a reliable biomarker of pancreas function.

  2024cites this paper
• Meconium Peritonitis in the Newborn with Cystic Fibrosis and Negative Neonatal Screening for Immunoreactive Trypsinogen: Clinical Case

  2024cites this paper
• Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis

  2022cites this paper
• Journal of Inborn Errors of Metabolism & Screening

  2021cites this paper
• History of Newborn Screening for Cystic Fibrosis—The Early Years

  2020cites this paper
• Neonatal Screening for Cystic Fibrosis: A Meta Analysis Study

  2019cites this paper
• Early manifestations of cystic fibrosis in a premature patient with complex meconium ileus at birth

  2015cites this paper
• Sweat conductivity and coulometric quantitative test in neonatal cystic fibrosis screening.

  2015cites this paper
• Manifestações precoces da fibrose cística em paciente prematuro com íleo meconial complexo ao nascimento

  2015cites this paper
• Cystic Fibrosis: Need for Mass Deployable Screening Methods

  2014cites this paper
• ST5 Paediatrician, Specialist Paediatric Cystic Fibrosis Dietitian, ST6 Paediatric Respiratory Medicine, Professor Child Health, Consultant Paediatric Respiratory Medicine and Reader in Neonatology Consultation: Neonatal Service Staff and Clinical Guideline Meeting

  2014cites this paper
• Thirty-years of screening for cystic fibrosis in East Anglia

  2012cites this paper
• La protéine CFTR : Implication et cible thérapeutique dans la maladie osseuse chez les patients atteints de mucoviscidose.

  2012cites this paper
• Neonatal biochemical reference ranges

  2012cites this paper
• Is Neonatale Screening op Mucoviscidose aangewezen in België?

  2010cites this paper
• European best practice guidelines for cystic fibrosis neonatal screening.

  2009cites this paper
• Psychosocial Aspects of Newborn Screening Programs for Cystic Fibrosis

  2008cites this paper
• Newborn screening methods for cystic fibrosis.

  2003cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Apport de la biologie moléculaire au dépistage néonatal de la mucoviscidose

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Novel mutations in the homogentisate- 1,2-dioxygenase gene identified in Slovak patients with alkaptonuria

  2000cites this paper
• Many deltaF508 heterozygote neonates with transient hypertrypsinaemia have a second, mild CFTR mutation.

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population

  2000cites this paper
• Polymorphisms in PTEN in breast cancer families

  1999cites this paper
• Clinical outcomes of newborn screening for cystic fibrosis

  1999cites this paper
• Neonatal screening for cystic fibrosis

  1998cites this paper
• Screening for Cystic Fibrosis

  1998cites this paper
• What is a cystic fibrosis diagnosis?

  1998cites this paper
• Multiplex Genotyping for Cystic Fibrosis from Filter Paper Blood Spots

  1998cites this paper
• Neonatal Screening for Cystic Fibrosis in the Trent Region (UK): Two-Stage Immunoreactive Trypsin Screening Compared with a Three-Stage Protocol with DNA Analysis as an Intermediate Step

  1997cites this paper
• Neonatal screening for inborn errors of metabolism: cost, yield and outcome.

  1997cites this paper
• Exocrine pancreatic function in cystic fibrosis.

  1996cites this paper
• Nutritional management of the infant with cystic fibrosis.

  1995cites this paper
• Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience

  1994cites this paper
• Early and late outcome of cystic fibrosis screening.

  1994cites this paper
• Laboratory screening for genetic disorders and birth defects.

  1994cites this paper
• Neonatal screening.

  1993cites this paper
• Newborn screening for cystic fibrosis: Its evolution and a review of the current situation

  1993cites this paper
• Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history.

  1993cites this paper